Elevated lipoprotein(a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR)

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 2, 2014, Pages 107-117

  Gerhardt, Andrea ^a,b   Howe, Nadja ^a   Krüssel, Jan Steffen ^a   Scharf, Ruediger Eberhard ^a   Zotz, Rainer Bernd ^a,c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Blutgerinnung Ulm   (Germany)

^c Centre for Blood Coagulation and Transfusion Medicine   (Germany)

Author keywords

Arterial thrombosis; Hereditary; Intrauterine growth restriction; Risk factors

Indexed keywords

LIPOPROTEIN A; THROMBOCYTE ANTIGEN; THROMBOCYTE ANTIGEN 1B; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTERY THROMBOSIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; GESTATIONAL AGE; HEREDITY; HUMAN; HUMAN CELL; INFANT; INTRAUTERINE GROWTH RETARDATION; LIPOPROTEIN BLOOD LEVEL; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOGENICITY;

ADULT; ANTIGENS, HUMAN PLATELET; FEMALE; FETAL GROWTH RETARDATION; HOMOZYGOTE; HUMANS; LIPOPROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 84894646076     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0902-3     Document Type: Article

References (44)

1. American College of Obstetricians and Gynecologists (2000) Intrauterine growth restriction: clinical management guidelines for obstetrician gynecologists. ACOG practice bulletin no. 12. American College of Obstetricians and Gynecologists, Washington, DC, pp 1-11
2. Isermann B, Nawroth PP (2007) Relevance of platelets in placental development and function. Hamostaseologie 27(4):263-267
3. Brosens JJ, Pijnenborg R, Brosens IA (2002) The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187(5):1416-1423
4. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340(1):9-13
5. Facco F, You W, Grobman W (2009) Genetic thrombophilias and intrauterine growth restriction: a meta-analysis. Obstet Gynecol 113(6):1206-1216
6. McIntire DD, Bloom SL, Casey BM, Leveno KJ (1999) Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 340(16):1234-1238
7. Barker DJ (1999) Fetal origins of cardiovascular disease. Ann Med 31(Suppl):13-16
8. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ (1989) Weight in infancy and death from ischaemic heart disease. Lancet 2(8663):577-580
9. Strauss RS (1997) Effects of the intrauterine environment on childhood growth. Br Med Bull 53(1):81-95
10. Ben-Ami S, Oron G, Ben-Haroush A, Blickstein D, Hod M, Bar J (2010) Primary atherothrombotic occlusive vascular events in premenopausal women with history of adverse pregnancy outcome. Thromb Res 125(2):124-127
11. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366(9499):1797-1803
12. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340(2):115-126
13. Berg K, Dahlen G, Borresen AL (1979) Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin Genet 16(5):347-352
14. Erqou S, Kaptoge S, Perry PL, Di AE, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302(4):412-423
15. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, Bennett D, Silveira A, Malarstig A, Green FR, Lathrop M, Gigante B, Leander K, De FU, Seedorf U, Hamsten A, Collins R, Watkins H, Farrall M (2009) Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med 361(26):2518-2528
16. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J (1999) Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 100(11):1154-1160
17. Smolders B, Lemmens R, Thijs V (2007) Lipoprotein(a) and stroke: a meta-analysis of observational studies. Stroke 38(6):1959-1966
18. Bray PF (2000) Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 7(5):284-289
19. Zotz RB, Winkelmann BR, Nauck M, Giers G, Maruhn-Debowski B, Marz W, Scharf RE (1998) Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79(4):731-735
20. Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF (2000) The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest 105(6):793-802
21. Zotz RB, Scharf RE (2002) Platelet receptor polymorphisms and their role in cardiovascular disease. J Lab Med 26(11/12):584-593
22. He L, Pappan LK, Grenache DG, Li Z, Tollefsen DM, Santoro SA, Zutter MM (2003) The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo. Blood 102(10):3652-3657
23. Goodall AH, Curzen N, Panesar M, Hurd C, Knight CJ, Ouwehand WH, Fox KM (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20(10):742-747
24. ACOG technical bulletin (1996) Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 53(2):175-183
25. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332(14):912-917
26. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698-3703
27. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den HM, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111-113
28. Unkelbach K, Kalb R, Santoso S, Kroll H, Mueller-Eckhardt C, Kiefel V (1995) Genomic RFLP typing of human platelet alloantigens Zw(PlA), Ko, Bak and Br (HPA-1, 2, 3, 5). Br J Haematol 89(1):169-176
29. Corral J, Rivera J, Gonzalez-Conejero R, Vicente V (1999) The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39(4):372-378
30. Kharazmi E, Dossus L, Rohrmann S, Kaaks R (2011) Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 97(1):49-54
31. Irgens HU, Reisaeter L, Irgens LM, Lie RT (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323(7323):1213-1217
32. Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A (2007) Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 26(1):39-50
33. Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357(9273):2002-2006
34. Smith GD, Harding S, Rosato M (2000) Relation between infants' birth weight and mothers' mortality: prospective observational study. BMJ 320(7238):839-840
35. Danesh J, Erqou S, Walker M, Thompson SG, Tipping R, Ford C, Pressel S, Walldius G, Jungner I, Folsom AR, Chambless LE, Knuiman M, Whincup PH, Wannamethee SG, Morris RW, Willeit J, Kiechl S, Santer P, Mayr A, Wald N, Ebrahim S, Lawlor DA, Yarnell JW, Gallacher J, Casiglia E, Tikhonoff V, Nietert PJ, Sutherland SE, Bachman DL, Keil JE, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Pilotto L, Simons L, McCallum J, Friedlander Y, Fowkes FG, Lee AJ, Smith FB, Taylor J, Guralnik J, Phillips C, Wallace R, Blazer D, Khaw KT, Jansson JH, Donfrancesco C, Salomaa V, Harald K, Jousilahti P, Vartiainen E, Woodward M, D'Agostino RB, Wolf PA, Vasan RS, Pencina MJ, Bladbjerg EM, Jorgensen T, Moller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Bjorkelund C, Cremer P, Nagel D, Tilvis R, Strandberg T, Rodriguez B, Bouter LM, Heine RJ, Dekker JM, Nijpels G, Stehouwer CD, Rimm E, Pai J, Sato S, Iso H, Kitamura A, Noda H, Goldbourt U, Salomaa V, Salonen JT, Nyyssonen K, Tuomainen TP, Deeg D, Poppelaars JL, Meade T, Cooper J, Hedblad B, Berglund G, Engstrom G, Doring A, Koenig W, Meisinger C, Mraz W, Kuller L, Selmer R, Tverdal A, Nystad W, Gillum R, Mussolino M, Hankinson S, Manson J, De SB, Knottenbelt C, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Naito Y, Holme I, Nakagawa H, Miura H, Ducimetiere P, Jouven X, Crespo C, Garcia-Palmieri M, Amouyel P, Arveiler D, Evans A, Ferrieres J, Schulte H, Assmann G, Shepherd J, Packard C, Sattar N, Cantin B, Lamarche B, Despres JP, Dagenais GR, Barrett-Connor E, Wingard D, Bettencourt R, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Trevisan M, Witteman J, Kardys I, Breteler M, Hofman A, Tunstall-Pedoe H, Tavendale R, Lowe GD, Ben-Shlomo Y, Howard BV, Zhang Y, Best L, Umans J, Onat A, Meade TW, Njolstad I, Mathiesen E, Lochen ML, Wilsgaard T, Gaziano JM, Stampfer M, Ridker P, Ulmer H, Diem G, Concin H, Rodeghiero F, Tosetto A, Brunner E, Shipley M, Buring J, Cobbe SM, Ford I, Robertson M, He Y, Ibanez AM, Feskens EJ, Kromhout D, Collins R, Di AE, Kaptoge S, Lewington S, Orfei L, Pennells L, Perry P, Ray K, Sarwar N, Scherman M, Thompson A, Watson S, Wensley F, White IR, Wood AM (2007) The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 22(12):839-869
36. Berg K, Roald B, Sande H (1994) High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 46(1 Spec No):52-56
37. Van Pampus MG, Koopman MM, Wolf H, Buller HR, Prins MH, van den Ende A (1999) Lipoprotein(a) concentrations in women with a history of severe preeclampsia-a case control study. Thromb Haemost 82(1):10-13
38. van Pampus MG, van den Ende A, Wolf H (1998) Elevated levels of lipoprotein(a) in women with preeclampsia. Am J Obstet Gynecol 179(4):1103-1104
39. Bar J, Harell D, Bardin R, Pardo J, Chen R, Hod M, Sullivan M (2002) The elevated plasma lipoprotein(a) concentrations in preeclampsia do not precede the development of the disorder. Thromb Res 105(1):19-23
40. Ogunyemi D, Ku W, Arkel Y (2002) The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy. J Thromb Thrombolysis 14(2):157-162
41. Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Kocak N (2010) A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol 63(2):126-136
42. Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS (2008) Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol 60(5):426-431
43. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369(9575):1791-1798
44. Redecha P, van Rooijen N, Torry D, Girardi G (2009) Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 113(17):4101-4109